BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 17991486)

  • 1. Distribution plasticity of the human estrogen receptor alpha in live cells: distinct imaging of consecutively expressed receptors.
    Pick H; Jankevics H; Vogel H
    J Mol Biol; 2007 Dec; 374(5):1213-23. PubMed ID: 17991486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
    Robertson JF; Nicholson RI; Bundred NJ; Anderson E; Rayter Z; Dowsett M; Fox JN; Gee JM; Webster A; Wakeling AE; Morris C; Dixon M
    Cancer Res; 2001 Sep; 61(18):6739-46. PubMed ID: 11559545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
    Yang Z; Barnes CJ; Kumar R
    Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
    Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
    Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein coupled estrogen receptor 1 mediated estrogenic neuroprotection against spinal cord injury.
    Hu R; Sun H; Zhang Q; Chen J; Wu N; Meng H; Cui G; Hu S; Li F; Lin J; Wan Q; Feng H
    Crit Care Med; 2012 Dec; 40(12):3230-7. PubMed ID: 22975889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic regulation of estrogen receptor-alpha isoform expression in the mouse fallopian tube: mechanistic insight into estrogen-dependent production and secretion of insulin-like growth factors.
    Shao R; Egecioglu E; Weijdegård B; Kopchick JJ; Fernandez-Rodriguez J; Andersson N; Billig H
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1430-42. PubMed ID: 17848632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-time distribution analysis reveals characteristic ligand-dependent interaction patterns of nuclear receptors in living cells.
    Jankevics H; Prummer M; Izewska P; Pick H; Leufgen K; Vogel H
    Biochemistry; 2005 Sep; 44(35):11676-83. PubMed ID: 16128568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design, chemical synthesis, and biological evaluation of agents that selectively photo-degrade the transcription factor estrogen receptor-α.
    Tsumura K; Suzuki A; Tsuzuki T; Tanimoto S; Kaneko H; Matsumura S; Imoto M; Umezawa K; Takahashi D; Toshima K
    Org Biomol Chem; 2011 Sep; 9(18):6357-66. PubMed ID: 21789304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short-incubation reporter-gene assay for high-throughput screening of estrogen receptor-alpha antagonists.
    Shi X; Zheng W; Schneeweis JE; Fischer PA; Strulovici B; Peekhaus NT
    Assay Drug Dev Technol; 2005 Aug; 3(4):393-400. PubMed ID: 16180994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer.
    DeFriend DJ; Howell A; Nicholson RI; Anderson E; Dowsett M; Mansel RE; Blamey RW; Bundred NJ; Robertson JF; Saunders C
    Cancer Res; 1994 Jan; 54(2):408-14. PubMed ID: 8275477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
    Kelley KM; Rowan BG; Ratnam M
    Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.
    Sumbayev VV; Bonefeld-Jørgensen EC; Wind T; Andreasen PA
    FEBS Lett; 2005 Jan; 579(2):541-8. PubMed ID: 15642373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent specific pure antiestrogen with clinical potential.
    Wakeling AE; Dukes M; Bowler J
    Cancer Res; 1991 Aug; 51(15):3867-73. PubMed ID: 1855205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.